3687 related articles for article (PubMed ID: 29188294)
1. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study.
Weng LC; Roetker NS; Lutsey PL; Alonso A; Guan W; Pankow JS; Folsom AR; Steffen LM; Pankratz N; Tang W
PLoS One; 2018; 13(4):e0195719. PubMed ID: 29649275
[TBL] [Abstract][Full Text] [Related]
3. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.
White J; Swerdlow DI; Preiss D; Fairhurst-Hunter Z; Keating BJ; Asselbergs FW; Sattar N; Humphries SE; Hingorani AD; Holmes MV
JAMA Cardiol; 2016 Sep; 1(6):692-9. PubMed ID: 27487401
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
5. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
Liang Z; Zhao L; Lou Y; Liu S
QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
[TBL] [Abstract][Full Text] [Related]
7. Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies.
Iwagami M; Goto A; Katagiri R; Sutoh Y; Koyanagi YN; Nakatochi M; Nakano S; Hanyuda A; Narita A; Shimizu A; Tanno K; Hozawa A; Kinoshita K; Oze I; Ito H; Yamaji T; Sawada N; Nakamura Y; Nakamura S; Kuriki K; Suzuki S; Hishida A; Kasugai Y; Imoto I; Suzuki M; Momozawa Y; Takeuchi K; Yamamoto M; Sasaki M; Matsuo K; Tsugane S; Wakai K; Iwasaki M
Cancer Prev Res (Phila); 2022 Dec; 15(12):827-836. PubMed ID: 36040498
[TBL] [Abstract][Full Text] [Related]
8. Association of lipid-modifying therapy with risk of obstructive sleep apnea: A drug-target mendelian randomization study.
Zou J; Qi S; Sun X; Zhang Y; Wang Y; Li Y; Zhao ZH; Lei D
Toxicol Appl Pharmacol; 2024 Apr; 485():116909. PubMed ID: 38521370
[TBL] [Abstract][Full Text] [Related]
9. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
Tan Z; Hong J; Sun A; Ding M; Shen J
Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
[TBL] [Abstract][Full Text] [Related]
10. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study.
Hindy G; Engström G; Larsson SC; Traylor M; Markus HS; Melander O; Orho-Melander M;
Stroke; 2018 Apr; 49(4):820-827. PubMed ID: 29535274
[TBL] [Abstract][Full Text] [Related]
11. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
12. Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank.
Wang Q; Wang Y; Lehto K; Pedersen NL; Williams DM; Hägg S
EBioMedicine; 2019 Jul; 45():487-494. PubMed ID: 31300347
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.
Georgakis MK; Malik R; Anderson CD; Parhofer KG; Hopewell JC; Dichgans M
Brain; 2020 Feb; 143(2):597-610. PubMed ID: 31968102
[TBL] [Abstract][Full Text] [Related]
14. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
[TBL] [Abstract][Full Text] [Related]
15. Mendelian randomization of blood lipids for coronary heart disease.
Holmes MV; Asselbergs FW; Palmer TM; Drenos F; Lanktree MB; Nelson CP; Dale CE; Padmanabhan S; Finan C; Swerdlow DI; Tragante V; van Iperen EP; Sivapalaratnam S; Shah S; Elbers CC; Shah T; Engmann J; Giambartolomei C; White J; Zabaneh D; Sofat R; McLachlan S; ; Doevendans PA; Balmforth AJ; Hall AS; North KE; Almoguera B; Hoogeveen RC; Cushman M; Fornage M; Patel SR; Redline S; Siscovick DS; Tsai MY; Karczewski KJ; Hofker MH; Verschuren WM; Bots ML; van der Schouw YT; Melander O; Dominiczak AF; Morris R; Ben-Shlomo Y; Price J; Kumari M; Baumert J; Peters A; Thorand B; Koenig W; Gaunt TR; Humphries SE; Clarke R; Watkins H; Farrall M; Wilson JG; Rich SS; de Bakker PI; Lange LA; Davey Smith G; Reiner AP; Talmud PJ; Kivimäki M; Lawlor DA; Dudbridge F; Samani NJ; Keating BJ; Hingorani AD; Casas JP
Eur Heart J; 2015 Mar; 36(9):539-50. PubMed ID: 24474739
[TBL] [Abstract][Full Text] [Related]
16. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
[TBL] [Abstract][Full Text] [Related]
17. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
18. Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study.
Tao H; Yu Z; Dong Y; Liu L; Peng L; Chen X
Front Immunol; 2023; 14():1160312. PubMed ID: 37350960
[TBL] [Abstract][Full Text] [Related]
19. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
[TBL] [Abstract][Full Text] [Related]
20. The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.
Yang S; Pudasaini R; Zhi H; Wang L
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]